United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by U.S. sales of its cannabidiol medicine Epidiolex.
Alfredo Pascual
Alfredo Pascual's Latest Posts
Impact of US election on global cannabis sector to emerge slowly, executives say
Implications of the U.S. elections on the cannabis industry stretch far beyond America's borders. (Click here for live coverage of the U.S. election results.) Industry executives in countries as far away as Australia, Jamaica and Uruguay are weighing how the results...
Italy backtracks on medical CBD decree
The Italian Ministry of Health declined to take action under a decree that would have added certain CBD preparations into the table of medicines in its narcotics law, according to a recent notice in the country’s Official Gazette.
Germany firmly rejects recreational marijuana legalization bill as hope fades for reform
The German federal parliament rejected a bill to legalize a "strictly controlled" adult-use cannabis market, dealing a major setback to recreational marijuana reform efforts in that country. The rejection came despite the fact that a majority of the members of the...
More medical cannabis products available in Peruvian pharmacies
The first finished, registered cannabis medicine became available to patients in Peruvian pharmacies this week, Marijuana Business Daily has learned.
Danish medical cannabis market sees positive quarter
Denmark’s medical cannabis pilot program notched another positive quarter, but the number of unique consumers remains well below the trial’s peak of a year ago.
New Uruguayan decree could position country as cannabis logistics hub
Companies operating bonded warehouses in Uruguay are now able to provide international logistics services for the cannabis industry, according to a recently approved decree.
Newly enforced law might harm Italy’s medical cannabis market, pharmacies warn
Italian regulators have reminded pharmacies they are barred from shipping medical cannabis preparations to customers, a major departure from how patients have accessed the medicine for years in the southern European country. Business and patient groups warn that a...
Applications open to supply France with free medical cannabis via pilot program
The French Minister of Solidarity and Health has signed a lengthy decree specifying how a small-scale pilot program will be supplied with medical cannabis that ultimately will be given to patients free of charge. That decree, signed Friday, was followed by the Agency...
Advice for cannabis executives who want to address social justice
The International Drug Policy Consortium (IDPC)'s new report about the responsible regulation of cannabis shines a light on why companies should address broader issues such as social justice and sustainability. The IDPC document lists 20 principles, mostly directed at...
German patient wins court case to have cannabis covered by insurance
A German patient won a long legal battle against her statutory health-insurance provider involving medical cannabis reimbursement. The Social Court of Berlin and Brandenburg ruled that the health insurer must cover the cost of dronabinol drops for at least one year....
Aurora Cannabis lists some Uruguay assets for sale as regional CEO departs
Canadian producer Aurora Cannabis has confirmed that some of its assets in Uruguay are for sale, and the CEO leading its subsidiary in the South American country is no longer with the company. Alejandro Antalich, a former chief executive of ICC Labs, departed the...
